Document is current
Any future updates will be listed below
-
Authors
Kislaya, Irina
Rakotoarivelo, Rivo Andry
Rasamoelina, Tahimandranto
Solonirina, Jeannine
Brito, André
Ratiaharison, Elveric Fesia
Razafindrakoto, Ravo
Razafindralava, Nantenaina Matthieu
Rakotozandrindrainy, Njary
Radomanana, Mickael
Andrianarivelo, Mala Rakoto
Klein, Philipp
Jaeger, Anna
Lorenz, Eva
Hameister, Jule
Hoekstra, Pytsje T.
Corstjens, Paul L. A. M.
Schwarz, Norbert Georg
van Dam, Govert J.
May, Jürgen
Marchese, Valentina
Rakotozandrindrainy, Raphäel
Fusco, Daniela
,
-
Funding
Funding for this research was provided by:
European & Developing Countries Clinical Trials Partnership (RIA2016MC-1626-FREEBILY)
Deutsches Zentrum für Infektionsforschung (TI 03.907)
Bernhard-Nocht-Institut für Tropenmedizin
- License Information
-
More Information
Article History
Received: 29 August 2025
Accepted: 30 November 2025
First Online: 4 December 2025
Declarations
:
: The freeBILy trial was implemented according to ICH-GCP guidelines in compliance with the Helsinki Declaration and other legal and ethical requirements. The study protocol received approval from the National Ethics Committee of Madagascar (ref. no 022-SANP/CERBM of 05/03/2018) and the Ethics Committee of the Hamburg State Medical Chamber in Germany (ref. no PV5966 of 18/03/2019).
: Not applicable.
: The authors declare no competing interests.
